Codexis Inc

Research Codexis Inc (CDXS) on Bullrun: market cap USD 211.79M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCDXS
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 211.79M
• Financial periodFY2025
• RevenueUSD 70.39M
• Revenue growth18.6%
• Net income-USD 43.97M
• Free cash flow-USD 23.85M
• Gross margin86.7%

Valuation Snapshot

latest market cap is USD 211.79M.

About Codexis Inc

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.

Frequently asked questions

What is Codexis Inc's market cap?

Codexis Inc's market capitalization is USD 211.79M.

What does Codexis Inc do?

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand,...